Alan R. Stewart insider trades
Open-market stock purchases and sales by Alan R. Stewart, Director at Calidi Biotherapeutics, Inc, from SEC Form 4 filings since Jun 12, 2017.
Track record: 0% of 14 scored buys are up 5% or more since purchase, averaging -67%.